Optimizing the care and health of women with inflammatory bowel disease

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Nee, Judy ^a   Feuerstein, Joseph D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; ORAL CONTRACEPTIVE AGENT; RIFAMPICIN; THALIDOMIDE; WART VIRUS VACCINE;

CANCER PREVENTION; CANCER SCREENING; CHRONICITY; CLINICAL DECISION MAKING; CONTRACEPTION; CROHN DISEASE; FAMILY PLANNING; FEMALE; FEMALE FERTILITY; GASTROENTEROLOGIST; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MENSTRUATION; QUALITY OF LIFE; REVIEW; SEXUAL HEALTH; ULCERATIVE COLITIS; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

EID: 84930658375     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/435820     Document Type: Review

References (86)

1. J. D. Feuerstein and A. S. Cheifetz, "Ulcerative colitis: epidemiology, diagnosis, and management," Mayo Clinic Proceedings, vol. 89, no. 11, pp. 1553-1563, 2014.
2. A. S. Cheifetz, "Management of active Crohn disease," The Journal of the American Medical Association, vol. 309, no. 20, pp. 2150-2158, 2013.
3. S.Wilks, "Morbid appearances in the intestine ofMiss Bankes," London Medical Times & Gazette, vol. 2, p. 264, 1859.
4. P. Nandivada, V. Poylin, and D. Nagle, "Advances in the surgical management of inflammatory bowel disease," Current Opinion in Gastroenterology, vol. 28, no. 1, pp. 47-51, 2012.
5. J. Cosnes, C. Gowerrousseau, P. Seksik, and A. Cortot, "Epidemiology and natural history of inflammatory bowel diseases," Gastroenterology, vol. 140, no. 6, pp. 1785-1794, 2011.
6. B. B. Crohn, L. Ginzburg, and G. D. Oppenheimer, "Regional ileitis: a pathological and clinical entity," The Journal of the American Medical Association, vol. 251, no. 1, pp. 73-79, 1932.
7. P. Rutgeerts, K. Geboes,G.Vantrappen, J. Beyls, R. Kerremans, and M. Hiele, "Predictability of the postoperative course of Crohn's disease," Gastroenterology, vol. 99, no. 4, pp. 956-963, 1990.
8. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review," Gastroenterology, vol. 142, no. 1, pp. 46-54.e42, 2012.
9. E. V. Loftus Jr., "Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences," Gastroenterology, vol. 126, no. 6, pp. 1504-1517, 2004.
10. E. I. Benchimol, K. J. Fortinsky, P. Gozdyra, M. van den Heuvel, J. van Limbergen, and A. M. Griffiths, "Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends," Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 423-439, 2011.
11. N. A. Molodecky, I. S. Soon, D. M. Rabi et al., "Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review," Gastroenterology, vol. 142, no. 1, pp. 46.e42-54.e42, 2012.
12. R. D. Johnston and R. F. A. Logan, "What is the peak age for onset of IBD?" Inflammatory Bowel Diseases, vol. 14, supplement 2, pp. S4-S5, 2008.
13. G. Vernier-Massouille, M. Balde, J. Salleron et al., "Natural history of pediatric Crohn's disease: a population-based cohort study," Gastroenterology, vol. 135, no. 4, pp. 1106-1113, 2008.
14. M. B. Heyman, B. S. Kirschner, B. D. Gold et al., "Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry," Journal of Pediatrics, vol. 146, no. 1, pp. 35-40, 2005.
15. S. Ghosh and R. Mitchell, "Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey," Journal of Crohn's and Colitis, vol. 1, no. 1, pp. 10-20, 2007.
16. H. R. Clearfield, "How does IBD affect quality of life?" Inflammatory Bowel Diseases, vol. 14, pp. S45-S46, 2008.
17. A. J. Muir, L. J. Edwards, L. L. Sanders et al., "A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis," The American Journal of Gastroenterology, vol. 96, no. 5, pp. 1480-1485, 2001.
18. A. Moradkhani, L. J. Beckman, and J. H. Tabibian, "Healthrelated quality of life in inflammatory bowel disease: psychosocial, clinical, socioeconomic, and demographic predictors," Journal of Crohn's and Colitis, vol. 7, no. 6, pp. 467-473, 2013.
19. M. de Boer, M. Grootenhuis, B. Derkx, and B. Last, "Healthrelated quality of life and psychosocial functioning of adolescents with inflammatory bowel disease," Inflammatory Bowel Diseases, vol. 11, no. 4, pp. 400-406, 2005.
20. R. K. Cross, O. Lapshin, and J. Finkelstein, "Patient subjective assessment of drug side effects in inflammatory bowel disease," Journal of Clinical Gastroenterology, vol. 42, no. 3, pp. 244-251, 2008.
21. L. M.MacKner, R. M. Bickmeier, andW.V. Crandall, "Academic achievement, attendance, and school-related quality of life in pediatric inflammatory bowel disease," Journal of Developmental & Behavioral Pediatrics, vol. 33, no. 2, pp. 106-111, 2012.
22. A. B. Ballinger, M. O. Savage, and I. R. Sanderson, "Delayed puberty associated with inflammatory bowel disease," Pediatric Research, vol. 53, no. 2, pp. 205-210, 2003.
23. A. Ferguson and D.M. Sedgwick, "Juvenile onset inflammatory bowel disease: height and body mass index in adult life," British Medical Journal, vol. 308, no. 6939, pp. 1259-1263, 1994.
24. R. Heuschkel, C. Salvestrini, R. M. Beattie, H. Hildebrand, T. Walters, and A. Griffiths, "Guidelines for the management of growth failure in childhood inflammatory bowel disease," Inflammatory Bowel Diseases, vol. 14, no. 6, pp. 839-849, 2008.
25. C. E. Brain and M. O. Savage, "Growth and puberty in chronic inflammatory bowel disease," Baillière's Clinical Gastroenterology, vol. 8, no. 1, pp. 83-100, 1994.
26. J. Moore, D. Barlow, D. Jewell, and S. Kennedy, "Do gastrointestinal symptoms vary with the menstrual cycle?" British Journal of Obstetrics and Gynaecology, vol. 105, no. 12, pp. 1322-1325, 1998.
27. M. T. Bernstein, L. A. Graff, L. E. Targownik et al., "Gastrointestinal symptoms before and during menses in women with IBD," Alimentary Pharmacology and Therapeutics, vol. 36, no. 2, pp. 135-144, 2012.
28. S. Saha, Y.-Q. Zhao, S. A. Shah et al., "Menstrual cycle changes in women with inflammatory bowel disease: a study from the Ocean State Crohn's and Colitis Area Registry," Inflammatory Bowel Diseases, vol. 20, no. 3, pp. 534-540, 2014.
29. S. M. Lim, C. M. Nam, Y. N. Kim et al., "The effect of the menstrual cycle on inflammatory bowel disease: a prospective study," Gut and Liver, vol. 7, no. 1, pp. 51-57, 2013.
30. S. Kane, B. Khatibi, and D. Reddy, "Higher incidence of abnormal Pap smears in women with inflammatory bowel disease,"The American Journal of Gastroenterology, vol. 103, no. 3, pp. 631-636, 2008.
31. H. Singh, A. A. Demers, Z. Nugent, S. M. Mahmud, E. V. Kliewer, and C. N. Bernstein, "Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study," Gastroenterology, vol. 136, no. 2, pp. 451-458, 2009.
32. M. A. Smith, P. M. Irving, A.M.Marinaki, and J. D. Sanderson, "Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease," Alimentary Pharmacology &Therapeutics, vol. 32, no. 2, pp. 119-130, 2010.
33. C. W. Lees, J. Critchley, N. Chee et al., "Lack of association between cervical dysplasia and IBD: a large case-control study," Inflammatory Bowel Diseases, vol. 15, no. 11, pp. 1621-1629, 2009.
34. C. Rungoe, J. Simonsen, L. Riis, M. Frisch, E. Langholz, and T. Jess, "Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study," Clinical Gastroenterology and Hepatology, vol. 13, no. 4, pp. 693-700.e1, 2015.
35. V. A.Moyer, "Screening for cervical cancer: U.S. preventive services task force recommendation statement," Annals of Internal Medicine, vol. 156, no. 12, pp. 880-891, 2012.
36. ACOG Committee on Practice Bulletins-Gynecology, "ACOG Practice Bulletin No. 117: Gynecologic care for women with human immunodeficiency virus," Obstetrics & Gynecology, vol. 116, no. 6, pp. 1492-1509, 2010.
37. H. Singh, Z. Nugent, A. A. Demers, and C. N. Bernstein, "Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study," Inflammatory Bowel Diseases, vol. 17, no. 8, pp. 1741-1750, 2011.
38. L. E. Markowitz, E. F. Dunne, M. Saraiya et al., "Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP)," Morbidity and MortalityWeekly Report, vol. 63, pp. 1-30, 2014.
39. S. K. Wasan, J. A. Coukos, and F. A. Farraye, "Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge," Inflammatory Bowel Diseases, vol. 17,no. 12, pp. 2536-2540, 2011.
40. A. B. Trachter, A. I. Rogers, and S. R. Leiblum, "Inflammatory bowel disease in women: impact on relationship and sexual health," Inflammatory Bowel Diseases, vol. 8, no. 6, pp. 413-421, 2002.
41. A. Timmer, D. Kemptner, A. Bauer, A. Takses, C. Ott, and A. Fürst, "Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis," BMC Gastroenterology, vol. 8, article 45, 2008.
42. L.Marín, M.Mañosa, E. Garcia-Planella et al., "Sexual function and patients' perceptions in inflammatory bowel disease: a casecontrol survey," Journal of Gastroenterology, vol. 48, no. 6, pp. 713-720, 2013.
43. G. A.Moody and J. F. Mayberry, "Perceived sexual dysfunction amongst patients with inflammatory bowel disease," Digestion, vol. 54, no. 4, pp. 256-260, 1993.
44. K. R. Muller, R. Prosser, P. Bampton, R. Mountifield, and J. M. Andrews, "Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions," Inflammatory Bowel Diseases, vol. 16, no. 4, pp. 657-663, 2010.
45. A. Timmer, A. Bauer, A. Dignass, and G. Rogler, "Sexual function in persons with inflammatory bowel disease: a survey with matched controls," Clinical Gastroenterology and Hepatology, vol. 5, no. 1, pp. 87-94, 2007.
46. B. Christensen, "Inflammatory bowel disease and sexual dysfunction," Gastroenterology & Hepatology, vol. 10, no. 1, pp. 53-55, 2014.
47. M. Scaglia, G. G. Delaini, and L. Hultén, "Sexual dysfunctions after conventional proctocolectomy," Chirurgia Italiana, vol. 44, no. 5-6, pp. 230-242, 1992.
48. A. M.Metcalf, R. R. Dozois, and K. A. Kelly, "Sexual function in women after proctocolectomy," Annals of Surgery, vol. 204, no. 6, pp. 624-627, 1986.
49. B.Damgaard, A.Wettergren, andP. Kirkegaard, "Social andsexual function following ileal pouch-anal anastomosis," Diseases of the Colon & Rectum, vol. 38, no. 3, pp. 286-289, 1995.
50. R. J. Davies, B. I. O'Connor, C. Victor, H.M.Macrae, Z. Cohen, and R. S.McLeod, "A prospective evaluation of sexual function and quality of life after ileal pouch-anal anastomosis," Diseases of the Colon & Rectum, vol. 51, no. 7, pp. 1032-1035, 2008.
51. M. S. Dunker,W.A. Bemelman, J. F. M. Slors, P. vanDuijvendijk, and D. J. Gouma, "Functional outcome, quality of life, body image, and cosmesis in patients after laparoscopic-assisted and conventional restorative proctocolectomy: a comparative study," Diseases of the Colon & Rectum, vol. 44, no. 12, pp. 1800-1807, 2001.
52. M. J. Follick, T. W. Smith, and D. C. Turk, "Psychosocial adjustment following ostomy," Health Psychology, vol. 3, no. 6, pp. 505-517, 1984.
53. P.Weerakoon, "Sexuality and the patient with a stoma," Sexuality and Disability, vol. 19, no. 2, pp. 121-129, 2001.
54. M. R. Gloeckner, "Partner reaction following ostomy surgery," Journal of Sex and MaritalTherapy, vol. 9, no. 3, pp. 182-190, 1983.
55. J. N. Brouillette, E. Pryor, and T. A. Fox Jr., "Evaluation of sexual dysfunction in the female following rectal resection and intestinal stoma," Diseases of the Colon and Rectum, vol. 24, no. 2, pp. 96-102, 1981.
56. R. Mountifield, P. Bampton, R. Prosser, K. Muller, and J. M. Andrews, "Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions," Inflammatory Bowel Diseases, vol. 15, no. 5, pp. 720-725, 2009.
57. S. R. Marri, C. Ahn, and A. L. Buchman, "Voluntary childlessness is increased in women with inflammatory bowel disease," Inflammatory Bowel Diseases, vol. 13, no. 5, pp. 591-599, 2007.
58. M. Mañosa, M. Navarro-Llavat, L. Marín, Y. Zabana, E. Cabré, and E.Domènech, "Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey," Scandinavian Journal of Gastroenterology, vol. 48, no. 4, pp. 427-432, 2013.
59. A.Waljee, J.Waljee,A.M.Morris, and P. D. R. Higgins, "Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis," Gut, vol. 55, no. 11, pp. 1575-1580, 2006.
60. U. Mahadevan, "Fertility and pregnancy in the patient with inflammatory bowel disease," Gut, vol. 55, no. 8, pp. 1198-1206, 2006.
61. V. Pabby, S. S. Oza, L. E. Dodge et al., "In vitro fertilization is successful in women with ulcerative colitis and ileal pouch anal anastomosis,"The American Journal of Gastroenterology, 2014.
62. M. Hudson, G. Flett, T. S. Sinclair, P.W. Brunt, A. Templeton, and N. A. G. Mowat, "Fertility and pregnancy in inflammatory bowel disease," International Journal of Gynecology&Obstetrics, vol. 58, no. 2, pp. 229-237, 1997.
63. S. W. Ng and U. Mahadevan, "My treatment approach to management of the pregnant patient with inflammatory bowel disease," Mayo Clinic Proceedings, vol. 89, no. 3, pp. 355-360, 2014.
64. R. A. Bennett, P. H. Rubin, and D. H. Present, "Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease," Gastroenterology, vol. 100, no. 6, pp. 1638-1643, 1991.
65. H.Yang, C. McElree, M.-P.Roth, F. Shanahan, S.R.Targan, and J. I. Rotter, "Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews," Gut, vol. 34, no. 4, pp. 517-524, 1993.
66. M. Cox, J. Tripp, and S. Blacksell, "Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network∗: 5-year report," Journal of Family Planning and Reproductive Health, vol. 28, no. 2, pp. 73-77, 2002.
67. J. G.Wakeman, "Exacerbation of Crohn's disease after insertion of a levonorgestrel intrauterine system: a case report," Journal of Family Planning and Reproductive Health Care, vol. 29, no. 3, p. 154, 2003.
68. L. B. Zapata, M. E. Paulen, C. Cansino, P. A. Marchbanks, and K. M. Curtis, "Contraceptive use among women with inflammatory bowel disease: a systematic review," Contraception, vol. 82, no. 1, pp. 72-85, 2010.
69. B.D. Dickinson, R.D. Altman,N.H.Nielsen, and M. L. Sterling, "Drug interactions between oral contraceptives and antibiotics," Obstetrics and Gynecology, vol. 98, no. 5, pp. 853-860, 2001.
70. ACOG Committee on Practice Bulletins-Gynecology, "ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexistingmedical conditions," Obstetrics&Gynecology, vol. 107, pp. 1453-1472, 2006.
71. A. Flynn and S. Kane, "Antibiotics and oral contraceptive efficacy in inflammatory bowel disease," The American Journal of Gastroenterology, vol. 106, no. 6, pp. 1174-1175, 2011.
72. S. E. Helms, D. L. Bredle, J. Zajic, D. Jarjoura, R. T. Brodell, and I. Krishnarao, "Oral contraceptive failure rates and oral antibiotics," Journal of the American Academy of Dermatology, vol. 36, no. 5, pp. 705-710, 1997.
73. F. Maggiolo, G. Puricelli, M. Dottorini, S. Caprioli, W. Bianchi, and F. Suter, "The effect of ciprofloxacin on oral contraceptive steroid treatments," Drugs under Experimental and Clinical Research, vol. 17, no. 9, pp. 451-454, 1991.
74. S. F. Grimmer, D. J. Back, M. L. Orme, A. Cowie, I. Gilmore, and J. Tjia, "The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy," Contraception, vol. 33, no. 1, pp. 51-59, 1986.
75. J. P. Hanker, "Gastrointestinal disease and oral contraception," American Journal of Obstetrics and Gynecology, vol. 163, no. 6, pp. 2204-2207, 1990.
76. L. Nilsson, A. Victor, J. Kral, E. Johansson, and N. Kock, "Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy," Contraception, vol. 31, no. 2, pp. 195-204, 1985.
77. J. Cornish, E. Tan, C. Simillis, S. Clark, J. Teare, and P. P. Tekkis, "The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis," The American Journal of Gastroenterology, vol. 103, no. 9, pp. 2394-2400, 2008.
78. H. Khalili, L. M. Higuchi, A. N. Ananthakrishnan et al., "Oral contraceptives, reproductive factors and risk of inflammatory bowel disease," Gut, vol. 62, no. 8, pp. 1153-1159, 2013.
79. J. P. Wright, "Factors influencing first relapse in patients with Crohn's disease," Journal of Clinical Gastroenterology, vol. 15,no. 1, pp. 12-16, 1992.
80. A. Bitton, M. A. Peppercorn, D. A. Antonioli et al., "Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis," Gastroenterology, vol. 120, no. 1, pp. 13-20, 2001.
81. J.Cosnes, F. Carbonnel, F. Carrat,L.Beaugerie, and J.-P.Gendre, "Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study," Gut, vol. 45, no. 2, pp. 218-222, 1999.
82. L.M.Gawron, A. Goldberger,A. J.Gawron, C. Hammond, and L. Keefer, "The impact of hormonal contraception on diseaserelated cyclical symptoms in women with inflammatory bowel diseases," Inflammatory Bowel Diseases, vol. 20, no. 10, pp. 1729-1733, 2014.
83. A. Lichtarowicz, C. Norman, B. Calcraft, J. S.Morris, J. Rhodes, and J.Mayberry, "A study of the menopause, smoking, and contraception in women with Crohn's disease," Quarterly Journal of Medicine, vol. 72, no. 267, pp. 623-631, 1989.
84. S. V. Kane and D. Reddy, "Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease," The American Journal of Gastroenterology, vol. 103, no. 5, pp. 1193-1196, 2008.
85. J. E. Rossouw, G. L. Anderson, R. L. Prentice et al., "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial," The Journal of the American Medical Association, vol. 288, pp. 321-333, 2002.
86. H. Khalili, L. M. Higuchi, A. N. Ananthakrishnan et al., "Hormone therapy increases risk of ulcerative colitis but not Crohn's disease," Gastroenterology, vol. 143, no. 5, pp. 1199-1206, 2012.